Zimmer Biomet (ZBH) PT Lowered to $141 at Oppenheimer
Tweet
Share
E-mailGet Alerts ZBH Hot Sheet
Price: $100.91 +1.44%
Rating Summary:
18 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
18 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
Oppenheimer analyst Steven Lichtman lowered the price target on Zimmer Biomet (NYSE: ZBH) to $141.00 (from $175.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2026
- JG Summit (JGS:PM) (JGSHF) PT Lowered to PHP28.50 at Macquarie
- Macquarie Downgrades Leader Harmonious Drive Systems (688017:CH) to Underperform
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
